26 insiders have filed at CVSA since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Beard, Stephen W. | Chairman & CEO | 445.2k | 1.28% | ||
| Malafronte Michael W | Director | 155.1k | 0.446% | 6 buys $3.9M | |
| Phelan Robert J. | Chief Financial Officer | 65.8k | 0.189% | ||
| Beck Douglas G. | SVP, Gc, Corp. Sec & Iss | 47.8k | 0.137% | ||
| Wardell Lisa W | Director | 44.3k | 0.127% | 22 sells $50.9M | |
| Danaher John W Md | Pres. - Adtalem Med & Vet | 38.7k | 0.111% | ||
| Cox Karen Sue | President, Chamberlain Univ. | 33.6k | 0.097% | ||
| Betz Michael | Pres. Walden University & Cdo | 33.3k | 0.096% | 1 sells $380k | |
| Trent Evan | President, Adtalem Elevate | 24.1k | 0.069% | ||
| Herrera Maurice | SVP - Chief Marketing Officer | 20.6k | 0.059% | 2 sells $828k | |
| Phelan Kenneth J | Director | 19.8k | 0.057% | 1 buys $50k | |
| James Cheryl | SVP, Chro | 17.5k | 0.05% | ||
| Kiser Georgette D. | Director | 17.5k | 0.05% | ||
| O'Keefe Sharon | Director | 16.6k | 0.048% | ||
| Krehbiel William V | Director | 16.3k | 0.047% | ||
| Liles Scott | President, Medical And Vet | 13.6k | 0.039% | ||
| Tom Steven | SVP Chief Customer Officer | 13.3k | 0.038% | ||
| Burke William W | Director | 10.4k | 0.03% | 3 sells $721k | |
| Hill Sara | Chro | 10.3k | 0.03% | ||
| Simpson Blake | SVP, Chief Comms & Ca Officer | 8.8k | 0.025% | 1 sells $33k | |
| Hrinak Donna J | Director | 8.2k | 0.024% | 3 sells $1.1M | |
| Gupta Mayur | Director | 6.7k | 0.019% | ||
| Gangadharan Manjunath | VP, Chief Accounting Officer | 5.7k | 0.016% | 5 sells $450k | |
| Deshazer Charles | Director | 5.1k | 0.015% | ||
| Vandenbosch Betty M. | Director | 2.6k | <0.01% | ||
| Noel Megan | Chief Corp. Affairs Officer | 2.2k | <0.01% |
Full register at boothcheck.com/insiders/CVSA. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.